Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine | Zendy

Isobel M. Blake | Zendy; Margarita Pons-Salort | Zendy; Natalie A. Molodecky | Zendy; Ousmane M. Diop | Zendy; Paul Chenoweth | Zendy; Ananda S Bandyopadhyay | Zendy; Michel Zaffran | Zendy; Roland W. Sutter | Zendy; Nicholas C. Grassly | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine

Author(s) -

Isobel M. Blake,

Margarita Pons-Salort,

Natalie A. Molodecky,

Ousmane M. Diop,

Paul Chenoweth,

Ananda S Bandyopadhyay,

Michel Zaffran,

Roland W. Sutter,

Nicholas C. Grassly

Publication year - 2018

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1716677

Subject(s) - poliovirus , virology , serotype , outbreak , inactivated poliovirus vaccine , medicine , poliomyelitis eradication , virus

Mass campaigns with oral poliovirus vaccine (OPV) have brought the world close to the eradication of wild poliovirus. However, to complete eradication, OPV must itself be withdrawn to prevent outbreaks of vaccine-derived poliovirus (VDPV). Synchronized global withdrawal of OPV began with serotype 2 OPV (OPV2) in April 2016, which presented the first test of the feasibility of eradicating all polioviruses.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research